Pharmacogenetics in Clinical Practice: Focus on Opioids

This series counts toward the new Drug Enforcement Administration (DEA) requirement for PAs treating and managing opioid use disorder (OUD) and substance use disorder (SUD). The series focuses on alcohol use disorder, pain management and opioids, dismantling the stigma, and more.

Learning Objectives

  • Describe the impact of pharmacogenetic variations on drug metabolism
  • Predict potential opioid adverse events based on a patient’s pharmacogenetic profile
  • Predict potential opioid drug interactions based on a patient’s pharmacogenetic profile

Additional Information

Partner: 
American Academy of Physician Associates
Course summary
Available credit: 
  • 1.00 AAPA Category I CME
Course opens: 
01/01/2024
Course expires: 
09/30/2024
Rating: 
0

Available Credit

  • 1.00 AAPA Category I CME
Please login or register to take this course.

This course is offered through American Academy of Physician Associates.

To take this course you will be redirected to American Academy of Physician Associates's website. You must login or create an account with American Academy of Physician Associates in order to complete this activity.